214 related articles for article (PubMed ID: 21357737)
1. Pathological signaling via platelet-derived growth factor receptor {alpha} involves chronic activation of Akt and suppression of p53.
Lei H; Velez G; Kazlauskas A
Mol Cell Biol; 2011 May; 31(9):1788-99. PubMed ID: 21357737
[TBL] [Abstract][Full Text] [Related]
2. Growth factors outside the PDGF family drive experimental PVR.
Lei H; Velez G; Hovland P; Hirose T; Gilbertson D; Kazlauskas A
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3394-403. PubMed ID: 19324843
[TBL] [Abstract][Full Text] [Related]
3. Expression of PDGFRα is a determinant of the PVR potential of ARPE19 cells.
Lei H; Rhéaume MA; Velez G; Mukai S; Kazlauskas A
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):5016-21. PubMed ID: 21642621
[TBL] [Abstract][Full Text] [Related]
4. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy.
Lei H; Hovland P; Velez G; Haran A; Gilbertson D; Hirose T; Kazlauskas A
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2335-42. PubMed ID: 17460299
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy.
Lei H; Rheaume MA; Kazlauskas A
Exp Eye Res; 2010 Mar; 90(3):376-81. PubMed ID: 19931527
[TBL] [Abstract][Full Text] [Related]
6. A novel function of p53: a gatekeeper of retinal detachment.
Lei H; Rheaume MA; Cui J; Mukai S; Maberley D; Samad A; Matsubara J; Kazlauskas A
Am J Pathol; 2012 Sep; 181(3):866-74. PubMed ID: 22901751
[TBL] [Abstract][Full Text] [Related]
7. PI3K-mediated PDGFRα signaling regulates survival and proliferation in skeletal development through p53-dependent intracellular pathways.
Fantauzzo KA; Soriano P
Genes Dev; 2014 May; 28(9):1005-17. PubMed ID: 24788519
[TBL] [Abstract][Full Text] [Related]
8. Interactions between cadherin-11 and platelet-derived growth factor receptor-alpha signaling link cell adhesion and proliferation.
Madarampalli B; Watts GFM; Panipinto PM; Nguygen HN; Brenner MB; Noss EH
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1516-1524. PubMed ID: 30876808
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy.
Andrews A; Balciunaite E; Leong FL; Tallquist M; Soriano P; Refojo M; Kazlauskas A
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2683-9. PubMed ID: 10509666
[TBL] [Abstract][Full Text] [Related]
10. Growth factors outside of the platelet-derived growth factor (PDGF) family employ reactive oxygen species/Src family kinases to activate PDGF receptor alpha and thereby promote proliferation and survival of cells.
Lei H; Kazlauskas A
J Biol Chem; 2009 Mar; 284(10):6329-36. PubMed ID: 19126548
[TBL] [Abstract][Full Text] [Related]
11. A reactive oxygen species-mediated, self-perpetuating loop persistently activates platelet-derived growth factor receptor α.
Lei H; Kazlauskas A
Mol Cell Biol; 2014 Jan; 34(1):110-22. PubMed ID: 24190966
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor receptor-α is essential for cardiac fibroblast survival.
Ivey MJ; Kuwabara JT; Riggsbee KL; Tallquist MD
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H330-H344. PubMed ID: 31125253
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses.
Pennock S; Kazlauskas A
Mol Cell Biol; 2012 May; 32(10):1955-66. PubMed ID: 22431518
[TBL] [Abstract][Full Text] [Related]
14. An in vivo gene therapy approach for experimental proliferative vitreoretinopathy using the truncated platelet-derived growth factor alpha receptor.
Ikuno Y; Kazlauskas A
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2406-11. PubMed ID: 12091444
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor.
Ikuno Y; Leong FL; Kazlauskas A
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3107-16. PubMed ID: 10967071
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor acts primarily via platelet-derived growth factor receptor α to promote proliferative vitreoretinopathy.
Pennock S; Haddock LJ; Mukai S; Kazlauskas A
Am J Pathol; 2014 Nov; 184(11):3052-68. PubMed ID: 25261788
[TBL] [Abstract][Full Text] [Related]
17. Ciliary transport regulates PDGF-AA/αα signaling via elevated mammalian target of rapamycin signaling and diminished PP2A activity.
Umberger NL; Caspary T
Mol Biol Cell; 2015 Jan; 26(2):350-8. PubMed ID: 25392303
[TBL] [Abstract][Full Text] [Related]
18. PDGF stimulation of Müller cell proliferation: Contributions of c-JNK and the PI3K/Akt pathway.
Moon SW; Chung EJ; Jung SA; Lee JH
Biochem Biophys Res Commun; 2009 Oct; 388(1):167-71. PubMed ID: 19653997
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma.
Yamada S; Imura Y; Nakai T; Nakai S; Yasuda N; Kaneko K; Outani H; Takenaka S; Hamada K; Myoui A; Araki N; Ueda T; Itoh K; Yoshikawa H; Naka N
BMC Cancer; 2017 May; 17(1):334. PubMed ID: 28511645
[TBL] [Abstract][Full Text] [Related]
20. Postnatal tendon growth and remodeling require platelet-derived growth factor receptor signaling.
Sugg KB; Markworth JF; Disser NP; Rizzi AM; Talarek JR; Sarver DC; Brooks SV; Mendias CL
Am J Physiol Cell Physiol; 2018 Apr; 314(4):C389-C403. PubMed ID: 29341790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
